Literature DB >> 26602387

Nonalcoholic fatty liver disease as trigger of cardiovascular and metabolic complication in metabolic syndrome.

Luca Miele1, Giovanni Gasbarrini2, Valentina Giorgio3, Antonio Gasbarrini2, Antonio Grieco2.   

Abstract

Entities:  

Mesh：

Year:  2015        PMID： 26602387     DOI： 10.1007/s11739-015-1346-x

Source DB:  PubMed          Journal:  Intern Emerg Med        ISSN： 1828-0447            Impact factor:   3.397


× No keyword cloud information.
  74 in total

Review 1.  The metabolic syndrome: definition, global impact, and pathophysiology.

Authors:  Matthew V Potenza; Jeffrey I Mechanick
Journal:  Nutr Clin Pract       Date:  2009 Oct-Nov       Impact factor: 3.080

2.  A metagenome-wide association study of gut microbiota in type 2 diabetes.

Authors:  Junjie Qin; Yingrui Li; Zhiming Cai; Shenghui Li; Jianfeng Zhu; Fan Zhang; Suisha Liang; Wenwei Zhang; Yuanlin Guan; Dongqian Shen; Yangqing Peng; Dongya Zhang; Zhuye Jie; Wenxian Wu; Youwen Qin; Wenbin Xue; Junhua Li; Lingchuan Han; Donghui Lu; Peixian Wu; Yali Dai; Xiaojuan Sun; Zesong Li; Aifa Tang; Shilong Zhong; Xiaoping Li; Weineng Chen; Ran Xu; Mingbang Wang; Qiang Feng; Meihua Gong; Jing Yu; Yanyan Zhang; Ming Zhang; Torben Hansen; Gaston Sanchez; Jeroen Raes; Gwen Falony; Shujiro Okuda; Mathieu Almeida; Emmanuelle LeChatelier; Pierre Renault; Nicolas Pons; Jean-Michel Batto; Zhaoxi Zhang; Hua Chen; Ruifu Yang; Weimou Zheng; Songgang Li; Huanming Yang; Jian Wang; S Dusko Ehrlich; Rasmus Nielsen; Oluf Pedersen; Karsten Kristiansen; Jun Wang
Journal:  Nature       Date:  2012-09-26       Impact factor: 49.962

3.  Ninety patients with nonalcoholic steatohepatitis: insulin resistance, familial tendency, and severity of disease.

Authors:  I R Willner; B Waters; S R Patil; A Reuben; J Morelli; C A Riely
Journal:  Am J Gastroenterol       Date:  2001-10       Impact factor: 10.864

Review 4.  From the metabolic syndrome to NAFLD or vice versa?

Authors:  Ester Vanni; Elisabetta Bugianesi; Anna Kotronen; Samuele De Minicis; Hannele Yki-Järvinen; Gianluca Svegliati-Baroni
Journal:  Dig Liver Dis       Date:  2010-03-06       Impact factor: 4.088

5.  Nonalcoholic fatty liver, steatohepatitis, and the metabolic syndrome.

Authors:  Giulio Marchesini; Elisabetta Bugianesi; Gabriele Forlani; Fernanda Cerrelli; Marco Lenzi; Rita Manini; Stefania Natale; Ester Vanni; Nicola Villanova; Nazario Melchionda; Mario Rizzetto
Journal:  Hepatology       Date:  2003-04       Impact factor: 17.425

6.  Association of metabolic syndrome components with insulin resistance in normal weight population: the Qazvin Metabolic Diseases study.

Authors:  S Hashemipour; N Esmailzadehha; H Hamid; S Oveisi; P Yakhchaliha; A Ziaee
Journal:  J Endocrinol Invest       Date:  2015-05-08       Impact factor: 4.256

7.  Effects of coffee on inflammatory cytokine gene expression in mice fed high-fat diets.

Authors:  Yoichi Fukushima; Masato Kasuga; Kazuwa Nakao; Iichiro Shimomura; Yuji Matsuzawa
Journal:  J Agric Food Chem       Date:  2009-12-09       Impact factor: 5.279

8.  Assessment of adiponectin and leptin as biomarkers of positive metabolic outcomes after lifestyle intervention in overweight and obese children.

Authors:  Valentina M Cambuli; M Cristina Musiu; Michela Incani; Monica Paderi; Roberto Serpe; Valeria Marras; Efisio Cossu; M Gisella Cavallo; Stefano Mariotti; Sandro Loche; Marco G Baroni
Journal:  J Clin Endocrinol Metab       Date:  2008-05-20       Impact factor: 5.958

Review 9.  The gut microbiota and obesity: from correlation to causality.

Authors:  Liping Zhao
Journal:  Nat Rev Microbiol       Date:  2013-08-05       Impact factor: 60.633

10.  Does chronic low-grade endotoxemia define susceptibility of obese humans to insulin resistance via dietary effects on gut microbiota?

Authors:  Daniel M Kemp
Journal:  Adipocyte       Date:  2013-04-23       Impact factor: 4.534
View more
  3 in total

1.  Pancreatic cancer: risk and preventive factors.

Authors:  Anna Licata; Giuseppe Montalto; Maurizio Soresi
Journal:  Intern Emerg Med       Date:  2018-02-07       Impact factor: 3.397

2.  Exploring the relationship between nonalcoholic fatty liver disease and pancreatic cancer by computed tomographic survey.

Authors:  Chao-Feng Chang; Yu-Chen Tseng; Hsin-Hung Huang; Yu-Lueng Shih; Tsai-Yuan Hsieh; Hsuan-Hwai Lin
Journal:  Intern Emerg Med       Date:  2017-12-12       Impact factor: 3.397

3.  SGL 121 Attenuates Nonalcoholic Fatty Liver Disease through Adjusting Lipid Metabolism Through AMPK Signaling Pathway.

Authors:  Da Eun Kim; Bo Yoon Chang; Byeong Min Jeon; Jong In Baek; Sun Chang Kim; Sung Yeon Kim
Journal:  Int J Mol Sci       Date:  2020-06-25       Impact factor: 5.923
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.